Cochrane Abstracts
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia: Cochrane systematic review
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Beta-lactam Versus Beta-lactam-aminoglycoside Combination Therapy in Cancer Patients With Neutropenia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432859/all/Beta_lactam_versus_beta_lactam_aminoglycoside_combination_therapy_in_cancer_patients_with_neutropenia:_Cochrane_systematic_review. Accessed 27 February 2021.
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432859/all/Beta_lactam_versus_beta_lactam_aminoglycoside_combination_therapy_in_cancer_patients_with_neutropenia:_Cochrane_systematic_review. Accessed February 27, 2021.
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432859/all/Beta_lactam_versus_beta_lactam_aminoglycoside_combination_therapy_in_cancer_patients_with_neutropenia:_Cochrane_systematic_review
Beta-lactam Versus Beta-lactam-aminoglycoside Combination Therapy in Cancer Patients With Neutropenia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 February 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432859/all/Beta_lactam_versus_beta_lactam_aminoglycoside_combination_therapy_in_cancer_patients_with_neutropenia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia: Cochrane systematic review
ID - 432859
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432859/all/Beta_lactam_versus_beta_lactam_aminoglycoside_combination_therapy_in_cancer_patients_with_neutropenia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
